1
|
- Fundamental Concepts in Immunology
- Program for Clinical Laboratory Science
- Unit - 04
- Soluble Components
- of The
- Immune System
|
2
|
- Reading assignment:
- Pages 78 - 89 of textbook
- Learning objectives:
- Those listed on page 79 of textbook
- Key terms:
- Those listed on page 79 of textbook
|
3
|
- A diverse group of soluble molecules secreted by a variety of cells and
include:
- Cytokines
- e
- Immunoglobulins
- e
- Complement components
|
4
|
- Definition:
- Cytokines are a group of proteins that are produced by different cell
populations and affect different target cells.
- Three functional groups of cytokines:
- eMediators and regulators of non-specific immune responses.
- Cytokine
- Produced by
- Target cell
- effects
- IL-1
- IL-12
- TNF"
- IFN-(
- macrophages
- T-cells & B-cells
- stimulate cell division
- all APC=s
- Th1 and NK cells
- enhances other IL=s
- macrophages
- tumors
- inflammatory mediator
- T8+, NK, Th1
- NK cells
- cell activation
- Cytokines
|
5
|
- Three functional groups of cytokines: cont=d
- eMediators and regulators of specific immune responses.
- Cytokine
- Produced by
- Target cell
- effects
- IL-2
- IL-4
- IL-5
- IFN-(
- T-cells
- T & NK-cells
- proliferation of antigen- specific cells & other immature cells
- T4 cells
- B-cells
- antibody switching to IgE
- T-cells
- B-cells
- growth & differentiation of eosinophils
- T8, Th1 & NK
- most cells
- B-cell activation, T-cell production of MHC-I, Th1 production of IL-2
and IL-2R
- Cytokines
|
6
|
- Three functional groups of cytokines: cont=d
- eRegulators of hematopoiesis.
- Cytokine
- Produced by
- Target cell
- effects
- IL-3
- IL-7
- GM-CSF
- M-CSF
- T-cells
- stem cells
- growth & differentiation of blood cells
- Stroma cells
- lymphocytes
- generate pre-T & pre-B cells
- macrophages
- myeloid stem
- growth & differentiation of myeloid line
- fibroblasts, macrophages
- monocytes
- stimulate production of monocytes & macrophages
- Cytokines
|
7
|
- Th1
- NK
- IL-2
- B-cells
- proliferation
- differentiation
- enhanced Ig production
- T-cells
- proliferation
- lymphokine production
- enhanced cytotoxic
- activity
- NK-cells
- activation
- enhanced cytotoxic
- activity
- macrophages
- increased cytotoxic
- activity
- enhanced IL-1
- secretion
- Cytokines
|
8
|
- T-cells
- macrophage
- NK
- IL-3
- B-cells
- enhanced Ig production
- mast-cells
- differentiation
- stem-cells
- growth of all stem cell populations
- macrophages
- increased cytotoxic activity
- enhanced phagocytic activity
- Cytokines
|
9
|
- Th2-cells
- IL-4
- B-cells
- enhanced proliferation
- enhanced CD23 & MHC-II expression
- IgG1, IgE & IgA secretion
- T-cells
- enhanced proliferation
- increased cytotoxic activity
- giant cell formation
- stem-cells
- growth of all stem cell populations
- macrophages
- increased cytotoxic activity
- enhanced antigen presenting
- enhanced MHC presenting
- Cytokines
|
10
|
- activated Th2 cells
- IL-5
- B-cells
- increased proliferation
- IgM, IgA & IgG secretion
- increased expression of IL-2R
- T-cells
- enhanced cytotoxicity
- eosinophils
- enhanced differentiation
- enhanced chemotaxis
- Cytokines
|
11
|
- stromal cells of bone marrow & thymus
- IL-7
- pre-B-cells
- increased proliferation
- thymocytes
- increased proliferation
- increased T8 cells
- T-cells
- increased proliferation
- increased expression of IL-2, IL-2R & CD71
- lymphoid stem cells
- control of proliferation
- Cytokines
|
12
|
- Th2-cells
- macrophage
- B-cells
- IL-10
- B-cells
- enhanced MHC-II expression
- enhanced growth
- mast-cells
- proliferation
- macrophages
- suppressed production of IL-1, IL-12, TNF", MHC-II
- suppresses Th1 cell function
- Cytokines
|
13
|
- Th1-cells
- NK-cells
- IFN-(
- B-cells
- enhanced IgG2
- decreased CD23, IgE, & IgG1
- counteracts IL-4
- NK-cells
- increased activity
- T-cells
- induce IL-2 & IL2R
- enhanced T suppressor activity
- enhanced cytotoxicity
- macrophages
- enhanced production of TNF", MHC-II
- enhanced antimicrobial & antitumor activity
- viral infected cells
- depressed viral growth
- Cytokines
|
14
|
- macrophages
- TNF-"
- All cells with TNF receptors
- increased cytotoxicity and antiviral activity
- increased fibroblasts and thymocytes production
- stimulates IL-1, IL-6, CD11b/CD18, & MHC-II
- inflammatory mediator
- regulates growth of normal cells
- induces weight loss
- Cytokines
|
15
|
- Antibodies
- Definition:
- Antibodies (immunoglobulins) are a group of proteins (globulins) found
on B-cells and in body fluids.
- Two functional groups of antibodies:
- eB-cell surface bound antibodies:
- eFree (soluble) antibodies in fluids:
- Usecreted by B lymphocytes
- Uact as receptors
- Uact as cell markers
- Usecreted by plasma cells
- Ubind to antigen with same specificity
- Cytokines
|
16
|
- Cytokines
- Fab portion
- Fc portion
- Fab = fragment antigen binding (where antigen binds)
- Fc = fragment crystallizable (responsible for biological functions)
- light chains
- 2 kappa (6)
- or
- 2 lambda (8)
- heavy chains
- 2 (
- or
- 2 "
- or
- 2 :
- or
- 2 *
- or
- 2 ,
- IgG
- IgA
- IgM
- IgD
- IgE
- carbohydrates
|
17
|
- Cytokines
- NORMAL ELECTROPHORESIS PATTERN
- DIRECTION OF MIGRATION
- (
- $
- "2
- "1
- Albumin
|
18
|
- Function:
- ebinding of antigen with same specificity via Fab portion
- ebind to various immune cells via Fc portion
- eserve as opsonins and thus enhance phagocytosis
- NOTE:opsonins are molecules that attach to an organism and promote or
enhance phagocytosis. Examples
include:
- Uantibodies
- Ucomplement components
- Cytokines
|
19
|
- Definition:
- a group of plasma and membrane proteins that, upon activation, produce
certain effects associated with the humoral immune responses.
- Humoral immune responses:
- eimmune adherance
- eosponization
- echemotaxis
- ekinin activation
- ecell lysis
- einflammation (anaphylatoxis)
- Cytokines
|
20
|
- Structure:
- efound in the $1 and $2 globulin region on protein electrophoretic
isolation
- enormally seen in the inactive form (zymogens) in plasma
- esystem may become activate through two pathways:
- Uclassical pathway
- Ualternative pathway
- ezymogens are converted to proteases by proteolysis
- eactivation process is a Acascade@ type reaction where one protease
activates a zymogen and the resulting protease activates another
zymogen, etc.
- Cytokines
|
21
|
- Complement System
- On pages 84 - 86AOne Step Further@ presents a more in-depth discussion
of the complement activation.
- This presentation is contained on a separate slide presentation called A
One Step Further #6"
- The student may call up the slide program OSF-6 later or click on the
arrow below to view slides now.
- Cytokines
|
22
|
- Destruction of complement in vitro:
- ecomplement components are heat labile (inactivated by heat)
- Uheating to 56oC for 30 minutes
- ecomplement components may also be inactivated by anticoagulants
- UEDTA
- ecomplement components may also be inactivated by chemicals
- Ucholine chloride
- Cytokines
|
23
|
- Functions of complement:
- eBiological effects
- Ubacterial opsonization
- mC3b binds to bacterial C3b receptor
- Uchemotaxis
- mC5a released during inflammatory response acts as an attractant for:
- -neutrophils
- -macrophages
- eCell lysis
- Uantibodies bind to cell surface
- Ucomplement activated via classical pathway
- Umembrane attack complex (MAC) formed
- Ucell destroyed via osmotic inbalance with H2O entering cell
- Cytokines
|
24
|
- Nomenclature of complement system:
- eClassical pathway & MAC
- Uidentified by numbers and letters:
- mC3i, C5i, etc. designate the zymogen (inactive form)
- __ __
- mC3a, C5b, etc. designate the protease (active form)
- mduring proteolysis to form proteases fragments are split off:
- -large fragment called Aa@ (i.e. C3a)
- -small fragment called Ab@ (i.e. C3b)
- eAlternative pathway & MAC
- Uidentified by letters preceded by factor:
- mfactor B, factor H, etc.
- Cytokines
|
25
|
- Press the ESC key to end program
|
26
|
- Complement Activation
- OSF - 6
- Pages 84 - 86
- Click here to return to main program
|
27
|
- Two enzymatic pathways available:
- eClassical pathway
- eAlternative pathway
- ˇfirst one discovered
- ˇactivated by immune complexes
- ˇactivated primarily by polysaccharide structures
- ¸microbial cell walls is an example
- Two enzymatic pathways join at:
- eClevage of C5 which results in:
- ˇformation of the Membrane Attack Complex (MAC)
- ¸this results in lysis of cell
|
28
|
- ethe sequence of activation is:
- Immune complex
- \
- C1q of C1 complex
- \
- C4
- -
- C4a
- \
- C4b
- \
- C2
- -
- C2a
- \
- C2b
- C4b
- \
- C2b
- -
- C3 convertase
- C3 convertase
- \
- C3
- -
- C3b
- C3b
- \
- C3 convertase
- -
- C5 convertase
- C5 convertase
- \
- C5
- -
- C5b
- C5b
- \
- C6
- \
- C7
- \
- C8
- \
- C9
- MAC
- cell lysis
|
29
|
- ethe sequence of activation is:
- C3
- -
- C3b
- (C3b is found normally in the blood due to hydrolysis of C3)
- C3b
- -
- binds to microbial surface
- C3b
- \
- Factor D
- \
- Factor B
- -
- C3 convertase
- C3 convertase
- \
- C3
- -
- C3b
- C3b
- \
- C3 convertase
- -
- C5 convertase
- C5 convertase
- \
- C5
- -
- C5b
- C5b
- \
- C6
- \
- \
- \
- C7
- C8
- C9
- MAC
- cell lysis
|
30
|
- eC1 INH
- eFactor I
- eFactor H
- eC4bp
- ˇinhibits C1 binding with immune complex
- ˇinhibits C3b
- ˇinhibits C3 convertase formation
- ˇinhibits C3b + Factor B & Factor D interaction
- ˇinhibits C3 convertase formation
- ˇbinds with C4
- ˇinhibits C3 convertase formation
|
31
|
- Click here to return to main program
|